carboplatin,durvalumab,gemcitabine,paclitaxel,vinorelbine,cisplatin,nivolumab,docetaxel,pemetrexed,ipilimumab,pembrolizumab
astrazeneca,merck,bms
['keynote,671', 'aegean', 'cm816', 'keynote 671', 'lcsm,(-blcsm)']
great discussion of keynote 671 by dr. at #asco23. notes challenges of comparing studies given differences in populations. but efs curves do appear to widen over time and plateau - perhaps more than cm816. and data more reassuring with longer f/u than aegean. #lcsm 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo